Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher Sells $2.2B in Senior Notes

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific has closed its offering of senior notes, raising $2.2 billion.

As reported last week, the firm offered $300 million aggregate principal amount of 2.05 percent senior notes due 2014; $900 million aggregate principal amount of 3.2 percent senior notes due 2016; and $1 billion aggregate principal amount of 4.5 percent senior notes due 2021.

The firm said in a filing today with the US Securities and Exchange Commission that the 2014 notes will mature on Feb. 21, 2014, the 2016 notes will mature on March 1, 2016, and the 2021 notes will mature on March 1, 2021.

Thermo Fisher will use the proceeds to pay for its $2.1 billion acquisition of Dionex, which was announced in December. Last week, the firm said that it had extended its tender offer to acquire all of the outstanding shares of Dionex for $118.50 per share until midnight, New York City time, on April 7.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.